GB0418580D0 - Clopidogrel salt - Google Patents

Clopidogrel salt

Info

Publication number
GB0418580D0
GB0418580D0 GBGB0418580.7A GB0418580A GB0418580D0 GB 0418580 D0 GB0418580 D0 GB 0418580D0 GB 0418580 A GB0418580 A GB 0418580A GB 0418580 D0 GB0418580 D0 GB 0418580D0
Authority
GB
United Kingdom
Prior art keywords
clopidogrel salt
clopidogrel
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0418580.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ivax Pharmaceuticals sro
Original Assignee
Ivax Pharmaceuticals sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Pharmaceuticals sro filed Critical Ivax Pharmaceuticals sro
Priority to GBGB0418580.7A priority Critical patent/GB0418580D0/en
Publication of GB0418580D0 publication Critical patent/GB0418580D0/en
Priority to PCT/US2005/029449 priority patent/WO2006023676A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0418580.7A 2004-08-21 2004-08-21 Clopidogrel salt Ceased GB0418580D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0418580.7A GB0418580D0 (en) 2004-08-21 2004-08-21 Clopidogrel salt
PCT/US2005/029449 WO2006023676A1 (en) 2004-08-21 2005-08-17 Clopidogrel napsylate salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0418580.7A GB0418580D0 (en) 2004-08-21 2004-08-21 Clopidogrel salt

Publications (1)

Publication Number Publication Date
GB0418580D0 true GB0418580D0 (en) 2004-09-22

Family

ID=33042363

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0418580.7A Ceased GB0418580D0 (en) 2004-08-21 2004-08-21 Clopidogrel salt

Country Status (2)

Country Link
GB (1) GB0418580D0 (en)
WO (1) WO2006023676A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8764820B2 (en) 2005-11-16 2014-07-01 Edwards Lifesciences Corporation Transapical heart valve delivery system and method
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US8439970B2 (en) 2009-07-14 2013-05-14 Edwards Lifesciences Corporation Transapical delivery system for heart valves
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities
US9381082B2 (en) 2011-04-22 2016-07-05 Edwards Lifesciences Corporation Devices, systems and methods for accurate positioning of a prosthetic valve
US10149757B2 (en) 2013-03-15 2018-12-11 Edwards Lifesciences Corporation System and method for transaortic delivery of a prosthetic heart valve
EP3134033B1 (en) 2014-05-29 2018-04-04 Edwards Lifesciences CardiAQ LLC Prosthesis and delivery device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2393181A (en) * 2002-09-19 2004-03-24 Cipla Ltd Amorphous clopidogrel
WO2005080890A1 (en) * 2004-02-24 2005-09-01 Siegfried Generics International Ag Pharmacologically acceptable salts of clopidogrel
EP1732932B1 (en) * 2004-04-09 2012-03-21 Hanmi Holdings Co., Ltd. Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same

Also Published As

Publication number Publication date
WO2006023676A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
AP2006003810A0 (en) 4-Phenylamino-quinazolin-6-yl-amides
EP1717239A4 (en) Substituted sym-triindole
EP1732560A4 (en) Substituted cinnolin-4-ylamines
HU0600293D0 (en) New rosuvastatine salt
ZA200711142B (en) Thienopyridines
IL180888A0 (en) Substituted n-acyl-2-aminothiazoles
ZA200800522B (en) New salt II
IL178216A0 (en) Clopidogrel salt and polymorphic forms thereof
SG119251A1 (en) Methods
GB0418580D0 (en) Clopidogrel salt
EP1802280A4 (en) Clopidogrel compositions
GB0415501D0 (en) Forming means
ZA200800488B (en) New Salt III
ZA200800515B (en) New Salt I
GB0403629D0 (en) Methods
EP1951694A4 (en) Salt forms
ZA200700723B (en) Substituted N-acyl-2-aminothiazoles
GB0423552D0 (en) Methods
GB0425955D0 (en) Salt form
HU0900197D0 (en) New olanzapine salt
GB0427702D0 (en) Novel salt
PL380677A1 (en) New clopidogrel salt
GB0415757D0 (en) Methods
GB0511000D0 (en) Novel salt
PL114637U1 (en) Shape

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)